SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-041629
Filing Date
2020-07-07
Accepted
2020-07-07 21:33:03
Documents
1
Period of Report
2020-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4284
  Complete submission text file 0001209191-20-041629.txt   5764
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERASTEM, INC. 117 NEEDHAM MA 02494
Business Address
Stuglik Brian M (Reporting) CIK: 0001716328 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35703 | Film No.: 201017137